Mizuho Reiterates Buy on Edwards Lifesciences, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Mizuho analyst Anthony Petrone reiterates a Buy rating on Edwards Lifesciences (NYSE:EW) and maintains a $95 price target.
June 27, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone reiterates a Buy rating on Edwards Lifesciences and maintains a $95 price target.
The Buy rating and maintained price target by Mizuho analyst Anthony Petrone indicate a positive outlook for Edwards Lifesciences. This could lead to increased investor confidence and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100